{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:33:32Z","timestamp":1778902412302,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ajog.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:15:15Z","timestamp":1504271715000},"page":"676.e1-676.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Trends in contraceptive use according to HIV status among privately insured women in the United States"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6668-6389","authenticated-orcid":false,"given":"Lisa B.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Monsour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi K.","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura K.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena P.","family":"Kourtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.08.006_bib1","unstructured":"Centers for Disease Control and Prevention. HIV Among Women. In: Secondary Centers for Disease Control and Prevention (CDC). Secondary HIV Among Women, 2015. Available at: http:\/\/www.cdc.gov\/hiv\/risk\/gender\/women. Accessed September 19, 2017."},{"key":"10.1016\/j.ajog.2017.08.006_bib2","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2017.08.006_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2458-9-314","article-title":"Prevention of mother-to-child transmission of HIV","volume":"9","author":"Mandala","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajog.2017.08.006_bib4","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use.\u00a02015. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/MEC-5\/en\/. Accessed September 19, 2017."},{"key":"10.1016\/j.ajog.2017.08.006_bib5","first-page":"1","article-title":"Current contraceptive use and variation by selected characteristics among women aged 15-44: United States, 2011-2013","author":"Daniels","year":"2015","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/j.ajog.2017.08.006_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/jwh.2006.0204","article-title":"Contraceptive use among US women with HIV","volume":"16","author":"Massad","year":"2007","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2017.08.006_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-157-5-201209040-00005","article-title":"US trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008","volume":"157","author":"Althoff","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2017.08.006_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.08.006_bib9","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Jan. 10,\u00a02011."},{"key":"10.1016\/j.ajog.2017.08.006_bib10","series-title":"Health research data for the real world: the MarketScan databases","author":"Hansen","year":"2012"},{"key":"10.1016\/j.ajog.2017.08.006_bib11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/AOG.0000000000001134","article-title":"Contraceptive use among women with medical conditions in a nationwide privately insured population","volume":"126","author":"Champaloux","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.08.006_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/AOG.0000000000001094","article-title":"Changes in use of long-acting reversible contraceptive methods among US women, 2009-2012","volume":"126","author":"Kavanaugh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.08.006_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/AOG.0b013e318269c8bb","article-title":"Trends in contraceptive use among women with human immunodeficiency virus","volume":"120","author":"Sun","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.08.006_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.08.006_bib15","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ajog.2007.03.004","article-title":"Young, seropositive, and pregnant: epidemiologic and psychosocial perspectives on pregnant adolescents with human immunodeficiency virus infection","volume":"197","author":"Koenig","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.08.006_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/QAI.0000000000000054","article-title":"Unplanned pregnancies among HIV-infected women in care\u2013United States","volume":"65","author":"Sutton","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2017.08.006_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/QAI.0000000000000014","article-title":"Pregnancy intentions among women living with HIV in the United States","volume":"65","author":"Rahangdale","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2017.08.006_bib18","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.ajog.2016.09.079","article-title":"Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative women","volume":"216","author":"Haddad","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.08.006_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2015.10.002","article-title":"The safety of hormonal contraceptives for women living with HIV and their sexual partners","volume":"93","author":"Phillips","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.08.006_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/QAD.0000000000001392","article-title":"Drug interactions between hormonal contraceptives and antiretrovirals","volume":"31","author":"Nanda","year":"2017","journal-title":"AIDS"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817309419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817309419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:18:19Z","timestamp":1757589499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817309419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002937817309419"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.08.006","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in contraceptive use according to HIV status among privately insured women in the United States","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}